Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Gross Profit (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Gross Profit for 2 consecutive years, with $49.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 3179.46% to $49.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.0 million, a 7704.53% increase, with the full-year FY2025 number at $62.0 million, up 7704.53% from a year prior.
  • Gross Profit was $49.0 million for Q4 2025 at Nuvation Bio, up from $9.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $49.0 million in Q4 2025 to a low of -$788000.0 in Q3 2024.